Skip to main content

Thymopoiesis, Regulatory T Cells, and TCRVβ Expression in Thymoma With and Without Myasthenia Gravis, and Modulatory Effects of Steroid Therapy

Journal of Clinical Immunology volume 28, pages 194–206 (2008)Cite this article

Abstract

We analyzed thymocyte and thymic regulatory T cell (CD4SPCD25+Foxp3+cells, Treg) development in thymoma with and without myasthenia gravis (MG, MG-thymoma, non-MG-thymoma) and in MG-associated non-neoplastic thymus (MG-NNT). An increased number of immature CD4+CD8−CD3− thymocytes through the CD4+CD8+ to CD4+CD8− transition and an abnormal T cell receptor Vβ (TCRVβ) development through the CD4+CD8+ to CD4−CD8+ transition were seen both in MG-and non-MG-thymomas. Terminal thymopoiesis, i.e., CD45RA+ cells within the CD4+CD8−CD3+ and CD8+CD4−CD3+ subsets, was skewed towards the CD4+ compartment in MG-thymoma and CD8+ compartment in non-MG-thymoma, but thymic export was increased only in the latter in keeping with the hypothesis that CD8+ lymphocytes may play a role in the initial stages of autosensitization and in disagreement with the relevance of an increased output of CD4+ T lymphocytes in paraneoplastic MG. Treg level in normal thymus and MG-NNT and both MG- and non-MG-thymoma was similar, and TCRVβ development in Treg cells was slightly altered in thymoma but irrespective of MG presence. Thus, the relevance of a defective Treg development in MG context remains to be established. Most alterations in thymopoiesis were corrected by therapeutic corticosteroid administration, and the effects of steroid administration may be mediated by thymic microenvironment.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. Vincent A. Unraveling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002;2:797–804.

    PubMed  Article  CAS  Google Scholar 

  2. Haynes BF, Hale LP. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components. Immunol Res 1998;18:175–92.

    PubMed  Article  CAS  Google Scholar 

  3. Willcox N. Myasthenia gravis. Curr Opin Immunol 1993;5:910–7.

    PubMed  Article  CAS  Google Scholar 

  4. Shiono H, Roxanis I, Zhang W, Sims GP, Meager A, Jacobson LW, et al. Scenarios for autoimmunization of T and B cells in myasthenia gravis. Ann N Y Acad Sci 2003;998:237–56.

    PubMed  Article  CAS  Google Scholar 

  5. Katzberg HD, Aziz T, Oger J. In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes. J Neurol Sci 2002;202:77–83.

    PubMed  Article  Google Scholar 

  6. Okumura M, Ohta M, Takeuchi Y, Shiono H, Inoue M, Fukuhara K, et al. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer. J Thorac Cardiovasc Surg 2003;126:1922–8.

    PubMed  Article  Google Scholar 

  7. Vincent A, Willcox N. The role of T-cells in the initiation of autoantibody responses in thymoma patients. Pathol Res Pract 1999;195:535–40.

    PubMed  CAS  Google Scholar 

  8. Müller-Hermelink HK, Marx A. Thymoma. Curr Opin Oncol 2000;12:426–33.

    PubMed  Article  Google Scholar 

  9. Nenninger R, Schultz A, Hoffacker V, Helmreich M, Wilisch A, Vandekerckhove B, et al. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Lab Invest 1998;78:743–53.

    PubMed  CAS  Google Scholar 

  10. Ströbel P, Helmreich M, Menioudakis G, Lewin SR, Rüdiger T, Bauer A, et al. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas. Blood 2002;100:159–66.

    PubMed  Article  Google Scholar 

  11. Ströbel P, Preisshofen T, Helmreich M, Müller-Hermelink HK, Marx A. Pathomechanisms of paraneoplastic myasthenia gravis. Clin Dev Immunol 2003;10:7–12.

    PubMed  Article  Google Scholar 

  12. Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della Marca G, Fattorossi A. Paraneoplastic diseases associated with thymoma. J Neurol 2007;254:756–62.

    PubMed  Article  Google Scholar 

  13. Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol 2001;50:64–72.

    PubMed  Article  CAS  Google Scholar 

  14. Machens A, Loliger C, Pichlmeier U, Emskotter T, Busch C, Izbicki JR. Correlation of thymic pathology with HLA in myasthenia gravis. Clin Immunol 1999;91:296–301.

    PubMed  Article  CAS  Google Scholar 

  15. Sun Y, Qiao J, Lu CZ, Zhao CB, Zhu XM, Xiao BG. Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy. Clin Immunol 2004;112:284–9.

    PubMed  Article  CAS  Google Scholar 

  16. Fattorossi A, Battaglia A, Buzzonetti A, Ciaraffa F, Scambia G, Evoli A. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology 2005;116:134–41.

    PubMed  Article  CAS  Google Scholar 

  17. Strobel P, Rosenwald A, Beyersdorf N, Kerkau T, Elert O, Murumagi A, et al. Selective loss of regulatory T cells in thymomas. Ann Neurol 2004;56:901–4.

    PubMed  Article  CAS  Google Scholar 

  18. Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della Marca G, Lauriola L, et al. Paraneoplastic diseases associated with thymoma. J Neurol 2007;254:756–62.

    PubMed  Article  Google Scholar 

  19. Balandina A, Lécart S, Dartevelle F, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005;105:735–41.

    PubMed  Article  CAS  Google Scholar 

  20. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol 2001;25:103–10.

    PubMed  Article  CAS  Google Scholar 

  21. Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304–11.

    PubMed  Article  Google Scholar 

  22. Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004;29:484–505.

    PubMed  Article  Google Scholar 

  23. Pacifici R, Zuccaro P, Cozzi-Lepre A, di Carlo S, Bacosi A, Fattorossi A. Quantification of the variation due to lysing technique in immunophenotyping of healthy and HIV-infected individuals. Clin Biochem 1998;31:165–72.

    PubMed  Article  CAS  Google Scholar 

  24. Battaglia A, Buzzonetti A, Monego G, Peri L, Ferrandina G, Fanfani F, et al. (2007) Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by pre-operative chemoradiation therapy in cervical cancer. Immunology (in press).

  25. Bertho JM, Demarquay C, Moulian N, Van Der Meeren A, Berrih-Aknin S, Gourmelon P. Phenotypic and immunohistological analyses of the human adult thymus: evidence for an active thymus during adult life. Cell Immunol 1997;179:30–40.

    PubMed  Article  CAS  Google Scholar 

  26. Takeuchi Y, Fujii Y, Okumura M, Inada K, Nakahara K, Matsuda H. Accumulation of immature CD3−CD4+CD8− single positive cells that lack CD69 in epithelial cell tumors of the human thymus. Cell Immunol 1995;161:181–7.

    PubMed  Article  CAS  Google Scholar 

  27. Inoue M, Fujii Y, Okumura M, Takeuchi Y, Shiono H, Miyoshi S, et al. Mature CD4 single positive thymocytes in human thymoma: T cells may differentiate in the thymic epithelial cell tumor. Pathobiology 1997;65:216–22.

    PubMed  CAS  Article  Google Scholar 

  28. Kadota Y, Okumura M, Miyoshi S, Kitagawa-Sakakida S, Inoue M, Shiono H, et al. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-γ). Clin Exp Immunol 2000;121:59–68.

    PubMed  Article  CAS  Google Scholar 

  29. Germain RN. T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol 2002;2:309–22.

    PubMed  Article  CAS  Google Scholar 

  30. Reinhardt C, Melms A. Skewed TCR V beta repertoire in human thymus persists after thymic emigration: influence of genomic imposition, thymic maturation and environmental challenge on human TCRV beta usage in vivo. Immunobiology 1998;199:74–86.

    PubMed  CAS  Google Scholar 

  31. Battaglia A, Ferrandina G, Buzzonetti A, Malinconico P, Legge F, Salutari V, et al. Lymphocyte populations in human lymph nodes. Alterations in CD4+CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire. Immunology 2003;110:304–12.

    PubMed  Article  CAS  Google Scholar 

  32. Berrih S, Safar D, Levasseur P, Gaud C, Bach JF. The in vivo effects of corticosteroids on thymocyte subsets in myasthenia gravis. J Clin Immunol 1984;4:92–7.

    PubMed  Article  CAS  Google Scholar 

  33. Willcox N. The thymus in myasthenia gravis patients, and the in vivo effects of corticosteroids on its cellularity, histology and functions. In: Kendall MD, Ritter MA, editors. Thymus update. Harwood Academic Publ, Amsterdam 1989, p 105–24.

  34. Willcox N, Schluep M, Sommer N, Campana D, Janossy G, Brown AN, et al. Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects. Q J Med 1989;73:1071–87.

    PubMed  CAS  Google Scholar 

  35. Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W, et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 2000;96:3872–9.

    PubMed  CAS  Google Scholar 

  36. Ye P, Kirschner DE. Measuring emigration of human thymocytes by T-cell receptor excision circles. Crit Rev Immunol 2002;22:483–97.

    PubMed  CAS  Google Scholar 

  37. Hazenberg MD, Borghans JA, de Boer RJ, Miedema F. Thymic output: a bad TREC record. Nat Immunol 2003;4:97–9. (qui probabilmente è 109).

    PubMed  Article  CAS  Google Scholar 

  38. Poulin JF, Viswanathan MN, Harris JM, Komanduri KV, Wieder E, Ringuette N, et al. Direct evidence for thymic function in adult humans. J Exp Med 1999;190:479–86.

    PubMed  Article  CAS  Google Scholar 

  39. Sempowski G, Thomasch J, Gooding M, Hale L, Edwards L, Ciafaloni E, et al. Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis. J Immunol 2001;166:2808–17.

    PubMed  CAS  Google Scholar 

  40. Steffens CM, Al-Harthi L, Shott S, Yogev R, Landay A. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes. Clin Immunol 2000;97:95–101.

    PubMed  Article  CAS  Google Scholar 

  41. Stephens LA, Mottet C, Mason D, Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001;31:1247–54.

    PubMed  Article  CAS  Google Scholar 

  42. Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E. Characterization of human CD25+CD4+ T cells in thymus, cord and adult blood. Immunology 2002;106:190–9.

    PubMed  Article  CAS  Google Scholar 

  43. Annunziato F, Cosmi L, Liotta F, Lazzeri E, Manetti R, Vanini V, et al. Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes. J Exp Med 2002;196:379–87.

    PubMed  Article  CAS  Google Scholar 

  44. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988;334:395–402.

    PubMed  Article  CAS  Google Scholar 

  45. Wakata N, Fukuya H, Niizuma M, Ishida T, Kinoshita M. Myasthenia gravis developing after discovery of thymoma. Clin Neurol Neurosurg 1992;94:303–6.

    PubMed  Article  CAS  Google Scholar 

  46. Mineo TC, Biancari F, D’Andrea V. Late onset of myasthenia gravis after total resection of thymoma: report of two cases. J Cardiovasc Surg 1996;37:531–3.

    CAS  Google Scholar 

  47. Grunewald J, Ahlberg R, Lefvert AK, DerSimonian H, Wigzell H, Janson CH. Abnormal T-cell expansion and V-gene usage in myasthenia gravis patients. Scand J Immunol 1991;34:161–8.

    PubMed  Article  CAS  Google Scholar 

  48. Truffault F, Cohen-Kaminsky S, Khalil I, Levasseur P, Berrih-Aknin S. Altered intrathymic T-cell repertoire in human myasthenia gravis. Ann Neurol 1997;41:731–41.

    PubMed  Article  CAS  Google Scholar 

  49. Navaneetham D, Penn AS, Howard JF Jr, Conti-Fine BM. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients. J Autoimmun 1998;11:621–33.

    PubMed  Article  CAS  Google Scholar 

  50. Tackenberg B, Kruth J, Bartholomaeus JE, Schlegel K, Oertel WH, Willcox N, et al. Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis. Eur J Immunol 2007;37:849–63.

    PubMed  Article  CAS  Google Scholar 

  51. Hale LP, Markert ML. Corticosteroids regulate epithelial cell differentiation and Hassal body formation in the human thymus. J Immunol 2004;172:617–24.

    PubMed  CAS  Google Scholar 

  52. Zubkova I, Mostowski H, Zaitseva M. Up-regulation of IL-7, stromal derived factor-1 alpha, thymus-expressed chemokine, and secondary lymphoid tissue chemokine gene expression in the stromal cells in response to thymocyte depletion: implication for thymus reconstitution. J Immunol 2005;175:2321–30.

    PubMed  CAS  Google Scholar 

  53. Okamoto Y, Douek DC, McFarland RD, Koup RA. Effects of exogenous interleukin-7 on human thymus function. Blood 2002;99:2851–58.

    PubMed  Article  CAS  Google Scholar 

  54. Gao Y, Kinoshita Y, Hato F, Tominaga K, Tsuji Y. Suppression of glucocorticoid-induced thymocyte apoptosis by co-culture with thymic epithelial cells. Cell Mol Biol 1996;42:227–34.

    PubMed  CAS  Google Scholar 

  55. Tateyama H, Takahashi E, Saito Y, Fukai I, Fujii Y, Niwa H, et al. Histopathologic changes of thymoma preoperatively treated with corticosteroids. Virchows Arch 2001;438:238–47.

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

Supported by Catholic University grant (Linea D1) to A. E.

Author information

Affiliations

  1. Laboratory of Immunology, Oncology Department, Catholic University, Campobasso, Italy

    Andrea Fattorossi, Alessandra Battaglia, Alexia Buzzonetti, Laura Peri & Giovanni Scambia

  2. Neuroscience Department, Catholic University, Rome, Italy

    Giacomo Minicuci, Raffaella Riso & Amelia Evoli

Authors
  1. Andrea Fattorossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandra Battaglia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexia Buzzonetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giacomo Minicuci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raffaella Riso
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laura Peri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giovanni Scambia
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Amelia Evoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Fattorossi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fattorossi, A., Battaglia, A., Buzzonetti, A. et al. Thymopoiesis, Regulatory T Cells, and TCRVβ Expression in Thymoma With and Without Myasthenia Gravis, and Modulatory Effects of Steroid Therapy. J Clin Immunol 28, 194–206 (2008). https://doi.org/10.1007/s10875-007-9147-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-007-9147-2

Keywords

  • Myasthenia gravis
  • thymopoiesis
  • steroids
  • recent thymic emigrants
  • thymoma
  • regulatory T cells
  • Foxp3
  • TCRVβ repertoire